BSD  Home Page
Search:

 
To automatically receive all Press Releases via email please submit the following:
First Name:
Last Name:
Email Address:
Organization:
 
07/17/2008: BSD Medical Responds to FDA on Its BSD-2000 PMA Application
07/10/2008: BSD Medical’s Year-to-Date Sales Up 66% from Prior Year
07/03/2008: Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical
06/30/2008: BSD Medical Reports Status on Submissions to FDA
06/25/2008: BSD-2000 Cancer Treatment System by BSD Medical Installed in Prestigious Liaocheng Peoples Hospital in China
06/18/2008: ESMO Guideline Working Group Recommends Hyperthermia Therapy as Treatment Option for Soft Tissue Sarcoma
06/10/2008: Italy to Receive First BSD-2000/3D Deep Regional Hyperthermia System
06/05/2008: Hyperthermia Therapy Featured as a “Powerful Tool” in Cancer Treatment by ABC Television (Philadelphia Affiliate)
06/03/2008: BSD Medical Representatives to Participate in Ribbon Cutting Ceremonies for Three New BSD-2000 Cancer Treatment Systems in China
05/28/2008: Phase III Clinical Study Using BSD Medical’s Systems for Treating Pancreatic Cancer to Be Announced at ASCO
05/20/2008: Treating Cancer with Hyperthermia Highlighted at the Vienna Joint German and Austrian Society of Radiation Oncology Meeting
05/02/2008: BSD Medical to Present Its Cancer Therapy Systems at the 2008 World Congress of Brachytherapy
04/29/2008: BSD Medical Announces Significant Advances in Treatment Technology at ICHO Congress in Munich
04/24/2008: Multiple Studies Demonstrate the Use of Hyperthermia Therapy in Treating Pancreatic Cancer
04/21/2008: BSD Medical to Open Trading on NASDAQ April 22
04/15/2008: BSD Medical Submits 510(k) Premarket Notification for MicroThermX®-100 Microwave Ablation System
04/10/2008: BSD Medical Corporation to Be Listed on the NASDAQ Stock Exchange
04/09/2008: BSD Medical Cites Highlights from Its Second Quarter 2008 Report * Second Quarter Sales Up by 123%
04/02/2008: ASTRO’s Official Journal Publishes 12-Year Survival Data Following Landmark Study of Cancer Treatment with Hyperthermia Therapy
03/18/2008: Review of Data from Eight U.S. Cancer Institutions Supports Use of Hyperthermia with Radiation for Treating Recurrent Breast Cancer
03/05/2008: 2008 ACRO Practice Management Guide Introduces Two Chapters on Hyperthermia Therapy
02/28/2008: Keynote Lecture on Hyperthermia Therapy Receives Standing Ovation at Biannual Meeting of the German Cancer Society
02/21/2008: BSD Medical Participates on Invitation at International Conference on Hyperthermic Oncology and Medicine in India
02/13/2008: Study Results Using the BSD-2000 Presented at International Congress on Anti-Cancer Treatment Held in Paris
02/04/2008: BSD Medical Adds Timothy C. McQuay to Board
01/23/2008: BSD-2000/3D/MR System Given ‘Grand Opening’ at Erlangen University Medical School
01/17/2008: BSD Medical Concludes Customer Training on New Hyperthermia Billing and Coding
01/15/2008: BSD-2000 Hyperthermia System Acquired by Long Beach Memorial Medical Center
01/10/2008: BSD Medical Releases First Quarter Results
01/07/2008: BSD Medical Receives Letter from FDA on BSD-2000
12/27/2007: Hyperthermia Offers a Beam of Hope amidst Gloomy Progress in Cancer Therapy
12/04/2007: BSD-2000 Cancer Treatment System Purchased by Nanchong Hospital in China
11/20/2007: Switzerland Receives First Hyperthermia Cancer Treatment System From BSD Medical
11/14/2007: BSD Medical Releases Year-end Results
11/07/2007: BSD Medical’s Cancer Treatment Systems Get an 80% Reimbursement Boost from Medicare
11/05/2007: BSD Medical Purchases Its Building
10/17/2007: Hyperthermia Combined with Radiation and Androgen Therapy Provides Positive Results with Reduced Toxicity for Prostate Cancer Treatments
10/09/2007: New Publication Report—Hyperthermia Plus Cisplatin as a Treatment for Recurrent Cervical Carcinoma for Previously Irradiated Patients
09/27/2007: BSD Medical Reports Upcoming Publication of 12-Year Cancer Survival Data Following Landmark Study of Hyperthermia Therapy
09/18/2007: BSD Medical’s Hyperthermia Therapy Now Offered at Northeast Radiation Oncology Center
09/13/2007: University of Dusseldorf Orders BSD-2000/3D/MR Cancer Treatment System
09/11/2007: “Generous Donation” by Dietmar-Hopp Foundation Launches Hyperthermia Therapy Program for Cancer Treatment at Heidelberg University
08/28/2007: Parents\' Initiative Pediatric Cancer Clinic Donation to Be Used for Purchase of a BSD-2000/3D/MR in Germany
08/23/2007: BSD Medical Announces Successful Conclusion of FDA Pre-approval Audit for BSD-2000 PMA Submission
08/14/2007: BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University
08/07/2007: BSD Medical’s Cancer Treatment Systems Get a Proposed 86% Reimbursement Boost
07/31/2007: BSD Medical Files Response to FDA Questions on BSD-2000 PMA Submission Following Meeting with FDA
07/25/2007: Famed Erlangen University Medical School Orders a BSD-2000/3D/MR
Email Us

HOME
COMPANY: Company Profile | Contact & Support
PATIENTS: Is Hyperthermia Right for You? | Treatment Providers | Advanced & Recurrent Cancer | Video on Hperthermia
PHYSICIANS: Hyperthermia as a Cancer Therapy | Clinical Reports | Advanced & Recurrent Cancer | Medical Reimbursement
PRODUCTS: | BSD 500 | BSD 2000 | BSD 2000/3D | BSD 2000/3D Video | BSD 2000/3D/MR
INVESTORS: Stock Quote | Company Profile | Financial Report | Directors & Officers | Market Makers | Code of Ethics | Forward Looking Statements | Information Request
LINKS

Copyright © 2005 BSD Medical Corporation. All rights reserved.